PharmaLogic Successfully Delivers First Dose for Novel Radiopharmaceutical in Sarcoma Study PharmaLogic Holdings has successfully supplied initial doses of an innovative FAP-targeted radiopharmaceutical for the ATLAS trial, aiming to treat aggressive sarcomas.

PharmaLogic Successfully Delivers First Dose for Novel Radiopharmaceutical in Sarcoma Study #United_States #Bronx #PharmaLogic #Ratio_Therapeutics #Ac-225-RTX-2358

TAG1 and PharmaLogic Join Forces to Enhance Radiopharmaceutical Development with Lead-212 Generators TAG1 Inc. and PharmaLogic have formed a strategic partnership to advance the development of Lead-212 generators, enhancing access to essential isotopes for treatments.

TAG1 and PharmaLogic Join Forces to Enhance Radiopharmaceutical Development with Lead-212 Generators #USA #St._Louis #PharmaLogic #Lead-212 #TAG1_Inc.

PharmaLogic Secures Majority Stake in Agilera Pharma AS to Enhance Global Holdings PharmaLogic Holdings Corp. has successfully acquired a majority stake in Agilera Pharma AS, expanding its capabilities in radiopharmaceuticals. This significant acquisition supports their strategy for integrated global development and manufacturing.

PharmaLogic Secures Majority Stake in Agilera Pharma AS to Enhance Global Holdings #United_States #Boca_Raton #radiopharmaceuticals #PharmaLogic #Agilera_Pharma

PharmaLogic Elevates Etienne Montagut to CEO, Charting New Course for Radiopharmaceuticals PharmaLogic announces the appointment of Etienne Montagut as President and CEO, signaling a strategic leadership evolution. With a wealth of experience, Montagut aims to enhance global patient access to radiopharmaceuticals.

PharmaLogic Elevates Etienne Montagut to CEO, Charting New Course for Radiopharmaceuticals #USA #Boca_Raton #radiopharmaceuticals #PharmaLogic #Etienne_Montagut

Life Molecular Imaging Expands Neuraceq® Availability Through Strategic Partnership in Salt Lake City Life Molecular Imaging has launched Neuraceq® in Salt Lake City to improve access to essential PET imaging for Alzheimer’s evaluation, enhancing patient care significantly.

Life Molecular Imaging Expands Neuraceq® Availability Through Strategic Partnership in Salt Lake City #USA #Salt_Lake_City #Neuraceq #Life_Molecular_Imaging #PharmaLogic

PharmaLogic Bolsters Radiopharmaceutical Expertise with Agilera Acquisition PharmaLogic Holdings announces its acquisition of a majority stake in Agilera Pharma, expanding its radiopharmaceutical capabilities on a global scale.

PharmaLogic Bolsters Radiopharmaceutical Expertise with Agilera Acquisition #None #Boca_Raton,_Florida #radiopharmaceuticals #PharmaLogic #Agilera